Researchers are excited about this new drug, a novel dual agonist showing promising results in initial trials for weight reduction . It acts by impacting two systems: GLP-1 and GIP, which , when https://sachinskps973485.ourcodeblog.com/41173659/a-new-prospect-for-size-reduction